Aesthetic nurse prescriber Michelle McLean has been named as the latest key opinion leader (KOL) for aesthetic device company BTL Aesthetics.
The company explains that McLean will be contributing to thought leadership, brand advocacy and clinical credibility. She will be doing this especially through her work with EMFACE to treat facial asymmetry. Her role will support ongoing marketing and educational efforts, helping elevate BTL’s presence within aesthetics, the brand explains.
James Carr, national sales manager at BTL Aesthetics UK, said, “We’re delighted to welcome McLean to our KOL partnerships. McLean’s results with EMFACE, particularly in treating facial asymmetry, have been outstanding. Her commitment to delivering exceptional patient outcomes perfectly aligns with our values, and we’re excited to collaborate as we continue to lead in non-invasive aesthetic innovation.”
